This decommissioned ERA site remains active temporarily to support our final migration steps to https://ualberta.scholaris.ca, ERA's new home. All new collections and items, including Spring 2025 theses, are at that site. For assistance, please contact erahelp@ualberta.ca.
Search
Skip to Search Results
Filter
Author / Creator / Contributor
Subject / Keyword
Year
Collections
Languages
Item type
Departments
Supervisors
-
Spring 2024
6-Mercaptopurine (6-MP) maintenance therapy is the mainstay for various types of leukemia and inflammatory bowel disease (IBD). 6-MP is associated with numerous adverse effects including gastrointestinal intolerance, myelotoxicity and hepatotoxicity. This can lead to therapy discontinuation which...
1 - 1 of 1